Rare diseases are a priority area of research funding for the European Union.
Major investment of more than €1.4 billion has been made in FP7 and Horizon 2020 to over 200 research and innovation projects involving rare diseases. Ceratium specialise in rare disease projects offering strategy development, proposal writing, project management and valorisation expertise. Our team have project managed Phase 2 and 3 clinical trial projects in a number of different and challenging rare diseases.